EVAg

Recombinant humanized monoclonal antibody against Schmallenberg orthobunyavirus, Isotype IgG1 / Igƙ, fused to Venus fluorophore

anti-African swine fever virus (ASFV), clone 2E10B3

Reverse genetics-based life cycle modelling system that allows modelling of Ebola virus genome replication and transcription, viral protein synthesis, virus assembly, budding, and Lloviu virus entry into target cells under BSL1 conditions.

Reverse genetics-based life cycle modelling system that can serve as negative control and is best used together with other trVLP systems that allows modelling of Ebola virus genome replication and transcription, viral protein synthesis, virus assembly, budding, and entry into target cells under BSL1 conditions.

Hybridoma cell culture supernatant containing anti-pan Orthobunyavirus antibodies; targeted antigen: Gc; clone: 6B2B2; immunization antigen: recombinant Gc Protein of LACV

anti-SARS-CoV-2 S protein (RBD, aa319-541) monoclonal antibody, clone 5E2B1

anti-SARS-CoV-2 S protein (S1 Ecto, aa1-1215) monoclonal antibody, clone 4B5C1

anti-SARS-CoV-2 S protein (NTD, aa17-304) monoclonal antibody, clone 6A5A3

Generation of recombinant chimeric monoclonal antibodies: murine monoclonal antibodies (hybridoma cells or total RNA have to be provided by the end-user) will be sequenced, cloned, recombinantly expressed in Expi293 cells, and purified via protein G. Available backbones for heavy and light chain constant regions are: mouse IgG1, Ig kappa; mouse IgG2a, Ig kappa; rabbit IgG, Ig kappa; human IgG1, Ig kappa; porcine IgG, Ig kappa; and bovine IgG, Ig kappa. Other backbones could possibly also generated uppon request.

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H12; clone: 20.1.2.a; immunization antigen: several inactivated AIV H8Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H13 and H16; clone: 14.2.6.c; immunization antigen: several inactivated AIV H13Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA1; clone: 15.2.7.c; immunization antigen: several inactivated AIV H1Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA2; clone: 4.3.6; immunization antigen: several inactivated AIV HxN2 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA7; clone: 17.1.5; immunization antigen: several inactivated AIV HxN7 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA8; clone: 14.2.3.b; immunization antigen: several inactivated AIV H3Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA9 and NA1; clone: 15.2.4; immunization antigen: several inactivated AIV H2Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NP; clone: 11.1.5; immunization antigen: several inactivated AIV isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NS1; clone: 21.1.1.A; immunization antigen: several inactivated AIV isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: Matrix Protein 1; clone: 4.2.1.A; immunization antigen: several inactivated AIV HxN2 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H1(0/1); clone: 12.2.2.A; immunization antigen: several inactivated AIV H1Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; clone: 13.2.7; targeted antigen: H2(0/1); immunization antigen: several inactivated AIV H2Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; clone: 18.2.4; targeted antigen: H3; immunization antigen: several inactivated AIV H3Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H4(0); clone: 5.2.4; immunization antigen: several inactivated AIV HxN6 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H5(0/1); clone: 10.2.1; immunization antigen: several inactivated AIV H5N1 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H6(0/1); clone: 11.1.7.c; immunization antigen: several inactivated AIV H6Nx isolates